Major challenges in finding solutions to cancer lie in lack of early symptoms and then rapid uncontrollable abnormal cell growth once it begins. Cancer continues to spread at an alarming rate, while progress in overcoming treatment barriers remains slow. Early detection holds the key to greatly improve outcomes by identifying cancer before it spreads. Stage zero diagnosis can prevent development of full-blown malignancies. Advancements in artificial intelligence are making early detection increasingly feasible, offering powerful tools for intervening in the disease’s earliest stages. This review provides a systematic analysis to establish link between artificial intelligence techniques and early detection of gynecological and andrological cancers using a variety of imaging techniques and bio-molecular markers.